SearchDictionaryMobileLogin

Fred Saad Selected Research

Hormones

08/2008The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone.
08/2008Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.
11/2007A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer.
08/2007Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer.
06/2006Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer.
04/2006Therapeutic approach to hormone-refractory prostate cancer.
01/2006Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis.
02/2005The role of bisphosphonates in hormone-refractory prostate cancer.
06/2004Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
10/2002A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Articles by Research Topic

Disease

35Prostatic Neoplasms (Prostate Cancer)
08/2008 - 12/2002
10Neoplasm Metastasis (Metastasis)
07/2008 - 02/2004
3Neoplasms (Cancer)
07/2008 - 04/2005
2Bone Resorption
07/2008 - 08/2005
2Pain (Aches)
04/2008 - 08/2002
2Urogenital Neoplasms
06/2006 - 11/2005
1Renal Cell Carcinoma (Grawitz Tumor)
06/2007
1Spinal Cord Compression
06/2007
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
08/2005
1Spontaneous Fractures (Pathological Fracture)
12/2002
1Carcinoma (Carcinomatosis)
10/2002

Drug/Important Bio-Agent (IBA)

14zoledronic acid (zoledronate)FDA Link
07/2008 - 10/2002
10HormonesIBA
08/2008 - 10/2002
6DiphosphonatesIBA
05/2006 - 09/2003
3Androgen Receptors (Androgen Receptor)IBA
05/2008 - 09/2006
3Prostate-Specific Antigen (Semenogelase)IBA
07/2007 - 05/2005
3NF-kappa B (NF-kB)IBA
12/2005 - 02/2004
2docetaxel (Taxotere)FDA Link
08/2008 - 08/2008
1Mitoxantrone (Novantrone)FDA LinkGeneric
08/2008
1Prednisone (Sone)FDA LinkGeneric
08/2008
1Carbon MonoxideIBA
05/2008
1RANK LigandIBA
05/2008
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
05/2008
1Biological Markers (Surrogate Marker)IBA
12/2007
1atrasentanIBA
11/2007
1Clodronic Acid (Clodronate)IBA
11/2007
1sunitinib (Sutent)FDA Link
06/2007
1NF-kappa B p52 SubunitIBA
05/2007
1I-kappa B KinaseIBA
01/2007
1Transcription Factors (Transcription Factor)IBA
01/2007
1Phytic Acid (Inositol Hexaphosphate)IBA
09/2006
1Casein Kinase II (Casein Kinase 2)IBA
12/2005
1alfuzosin (UroXatral)FDA Link
08/2005
1Lidocaine (Xylocaine)FDA LinkGeneric
08/2002

Therapy/Procedure

4Prostatectomy (Retropubic Prostatectomy)
08/2008 - 08/2007
1Aftercare (After-Treatment)
09/2006